1. Molecular docking
Protein-like receptor ribbons, a defined binding pocket, and a small-molecule ligand docking into the active site.
Kangwon National University · College of Pharmacy
We integrate molecular docking, ADME/Tox experiments, in vitro and in vivo PK/PD, LC-MS/MS bioanalysis, PBPK/PopPK modeling, and machine learning to translate pharmacokinetic mechanisms into decision-grade evidence.
Protein-like receptor ribbons, a defined binding pocket, and a small-molecule ligand docking into the active site.
Gut absorption, hepatic CYP metabolism, transporter-mediated distribution, and renal excretion.
Autosampler injection, LC separation, Q1–Q2–Q3 ion transition, dynamic chromatogram and MS spectrum.
Organ compartments, virtual populations, DDI scenarios, and changing concentration-time profiles.
Research
A compact view of the lab pipeline: mechanism-level molecular and ADME evidence, quantitative bioanalysis, translational PK/PD, and model-informed simulation.
Focus 01
Mechanistic interpretation of absorption, metabolism, transporter-mediated distribution, excretion, toxicity-related exposure, and in vitro/in vivo PK/PD evidence.
Focus 02
Quantitative drug analysis in biological matrices, MRM transition design, metabolite profiling, and time-resolved mass spectral interpretation.
Focus 03
Physiological organ models, virtual populations, dose-exposure prediction, covariate effects, and DDI scenarios under inducer/inhibitor conditions.
Focus 04
Data integration across molecular features, physicochemical descriptors, ADME assays, bioanalytical outputs, and patient-level covariates.
Publications
Recent 10 papers are shown first. Use the button to expand the full list.
People
Principal Investigator
Professor, College of Pharmacy, Kangwon National University